InfuSystem Holdings, Inc.
Moat Score — InfuSystem Holdings, Inc.
Total Moat Score
11 / 30
| Moat Factor | Score | Analysis |
|---|---|---|
| Intangible Assets Patents, trademarks, brand strength, or regulatory licenses that protect a company's products or services from being freely copied by competitors. | 2 / 5 | InfuSystem's EXPRESS/InfuConnect billing-integration platform and proprietary BlockPain Dashboard provide modest software differentiation, but the company does not develop the underlying pump technology itself (it is a service and logistics layer), limiting the depth of its intangible-asset moat. |
| Cost Advantage A durable ability to produce goods or services more cheaply than competitors — through scale, unique access to cheap inputs, location, or process — that lets a company undercut rivals or out-earn them at the same price. | 3 / 5 | A $109.1 million rental fleet, seven-location national footprint enabling same/next-day delivery, and in-house biomedical repair capability give InfuSystem real scale and logistics cost advantages over smaller regional DME providers, though not over larger national competitors with similar scale. |
| Pricing Power The ability to raise prices without losing meaningful business, because the product or service is differentiated, mission-critical, or has few good substitutes. | 1 / 5 | Revenue depends on pre-negotiated or proprietary fee schedules with roughly 840 third-party payer networks, largely set by Medicare and private-payer reimbursement rates rather than InfuSystem's own pricing discretion, which sharply limits pricing power. |
| Network Effect The product or service becomes more valuable to every user as more people or organizations use it, making an established leader harder to displace. | 0 / 5 | DME servicing and infusion-pump logistics carry no network effect; the value InfuSystem provides to one oncology practice does not increase because other practices also use its services. |
| Switching Costs The money, time, or operational disruption a customer would face switching to a competitor, which locks in existing customers and supports renewals. | 3 / 5 | Long-standing oncology provider relationships, integrated billing workflows (EXPRESS/InfuConnect), and established nursing-support processes create real switching friction for providers who would need to requalify a new DME partner across billing, logistics, and clinical workflows. |
| Efficient Scale A market that can only profitably support a small number of players, so incumbents face limited threat from new entrants even without other defenses. | 2 / 5 | The DME/oncology-infusion services market supports multiple national and regional providers alongside hospital-owned and physician-retained alternatives, so the market is not so narrow that it structurally excludes additional well-resourced competitors. |